This review discusses the recent literature (2006–2020) about the epidemiology, clinical presentation, diagnosis, and management of infants with congenital or perinatal tuberculosis (TB). While the incidence of childhood TB is declining in the United States and worldwide, many case reports describe how clinical suspicion for neonatal TB is raised only if an ill-appearing neonate does not improve with broad-spectrum antibiotics. Furthermore, the delay in initiating appropriate anti-TB therapy often results in the need for significant cardiopulmonary support and/or an increase in mortality. This review summarizes important clinical indications in the maternal and newborn history, the evaluation of an infant with possible TB exposure, and step-by-step recommendations for the treatment and follow-up of infants with TB.
Congenital and Perinatal Tuberculosis
Dr Hageman owns stock in Owlet Inc. Drs Shao and Shulman have disclosed no financial relationships relevant to this article. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device.
- Views Icon Views
- Share Icon Share
- Search Site
Yi Shao, Joseph R. Hageman, Stanford T. Shulman; Congenital and Perinatal Tuberculosis. Neoreviews September 2021; 22 (9): e600–e605. https://doi.org/10.1542/neo.22-9-e600
Download citation file: